Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew O Barrett

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Molecules (Basel, Switzerland)|April 10, 2014
Synthesis of extended uridine phosphonates derived from an allosteric P2Y2 receptor ligandLijun Song, Martijn D P Risseeuw, Izet Karalic, et al.
Molecular Pharmacology|April 18, 2013
A selective high-affinity antagonist of the P2Y14 receptor inhibits UDP-glucose-stimulated chemotaxis of human neutrophilsMatthew O Barrett, Juliana I Sesma, Christopher B Ball, et al.
Journal of Medicinal Chemistry|April 10, 2014
4-Alkyloxyimino derivatives of uridine-5'-triphosphate: distal modification of potent agonists as a strategy for molecular probes of P2Y2, P2Y4, and P2Y6 receptorsP Suresh Jayasekara, Matthew O Barrett, Christopher B Ball, et al.
Bioorganic & Medicinal Chemistry|March 6, 2012
Synthesis and P2Y₂ receptor agonist activities of uridine 5'-phosphonate analoguesSara Van Poecke, Matthew O Barrett, T Santhosh Kumar, et al.
Journal of Medicinal Chemistry|May 3, 2011
Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphate δ-ester modifications as selective agonists of the P2Y(4) receptorHiroshi Maruoka, M P Suresh Jayasekara, Matthew O Barrett, et al.
Medchemcomm|July 11, 2015
4-Alkyloxyimino-cytosine nucleotides: tethering approaches to molecular probes for the P2Y<sub>6</sub> receptorP Suresh Jayasekara, Matthew O Barrett, Christopher B Ball, et al.
Molecular Pharmacology|September 18, 2009
Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptorRhonda L Carter, Ingrid P Fricks, Matthew O Barrett, et al.
Journal of Medicinal Chemistry|May 8, 2010
Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modificationsHiroshi Maruoka, Matthew O Barrett, Hyojin Ko, et al.
Bioconjugate Chemistry|February 4, 2010
Polyamidoamine (PAMAM) dendrimer conjugates of "clickable" agonists of the A3 adenosine receptor and coactivation of the P2Y14 receptor by a tethered nucleotideDilip K Tosh, Lena S Yoo, Moshe Chinn, et al.
ACS Chemical Biology|October 10, 2014
Exploring a 2-naphthoic acid template for the structure-based design of P2Y14 receptor antagonist molecular probesEvgeny Kiselev, Matthew O Barrett, Vsevolod Katritch, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Molecules (Basel, Switzerland)|April 10, 2014
Synthesis of extended uridine phosphonates derived from an allosteric P2Y2 receptor ligandLijun Song, Martijn D P Risseeuw, Izet Karalic, et al.
Molecular Pharmacology|April 18, 2013
A selective high-affinity antagonist of the P2Y14 receptor inhibits UDP-glucose-stimulated chemotaxis of human neutrophilsMatthew O Barrett, Juliana I Sesma, Christopher B Ball, et al.
Journal of Medicinal Chemistry|April 10, 2014
4-Alkyloxyimino derivatives of uridine-5'-triphosphate: distal modification of potent agonists as a strategy for molecular probes of P2Y2, P2Y4, and P2Y6 receptorsP Suresh Jayasekara, Matthew O Barrett, Christopher B Ball, et al.
Bioorganic & Medicinal Chemistry|March 6, 2012
Synthesis and P2Y₂ receptor agonist activities of uridine 5'-phosphonate analoguesSara Van Poecke, Matthew O Barrett, T Santhosh Kumar, et al.
Journal of Medicinal Chemistry|May 3, 2011
Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphate δ-ester modifications as selective agonists of the P2Y(4) receptorHiroshi Maruoka, M P Suresh Jayasekara, Matthew O Barrett, et al.
Medchemcomm|July 11, 2015
4-Alkyloxyimino-cytosine nucleotides: tethering approaches to molecular probes for the P2Y<sub>6</sub> receptorP Suresh Jayasekara, Matthew O Barrett, Christopher B Ball, et al.
Molecular Pharmacology|September 18, 2009
Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptorRhonda L Carter, Ingrid P Fricks, Matthew O Barrett, et al.
Journal of Medicinal Chemistry|May 8, 2010
Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modificationsHiroshi Maruoka, Matthew O Barrett, Hyojin Ko, et al.
Bioconjugate Chemistry|February 4, 2010
Polyamidoamine (PAMAM) dendrimer conjugates of "clickable" agonists of the A3 adenosine receptor and coactivation of the P2Y14 receptor by a tethered nucleotideDilip K Tosh, Lena S Yoo, Moshe Chinn, et al.
ACS Chemical Biology|October 10, 2014
Exploring a 2-naphthoic acid template for the structure-based design of P2Y14 receptor antagonist molecular probesEvgeny Kiselev, Matthew O Barrett, Vsevolod Katritch, et al.
Pageof 2